Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 63975 entries
Sorted by: Best Match Show Resources per page
Paraneoplastic syndromes in olfactory neuroblastoma.

Contemporary oncology (Poznan, Poland)

Kunc M, Gabrych A, Czapiewski P, Sworczak K.
PMID: 26199564
Contemp Oncol (Pozn). 2015;19(1):6-16. doi: 10.5114/wo.2015.46283. Epub 2015 Mar 26.

Olfactory neuroblastoma (ONB) is a rare malignant neoplasm of sinonasal tract, derived from olfactory epithelium. Unilateral nasal obstruction, epistaxis, sinusitis, and headaches are common symptoms. Olfactory neuroblastoma shows neuroendocrine differentiation and similarly to other neuroendocrine tumors can produce several...

Cite
Kunc M, Gabrych A, Czapiewski P, et al. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn). 2015;19(1):6-16doi: 10.5114/wo.2015.46283.
Kunc, M., Gabrych, A., Czapiewski, P., & Sworczak, K. (2015). Paraneoplastic syndromes in olfactory neuroblastoma. Contemporary oncology (Poznan, Poland), 19(1), 6-16. https://doi.org/10.5114/wo.2015.46283
Kunc, Michał, et al. "Paraneoplastic syndromes in olfactory neuroblastoma." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 6-16. doi: https://doi.org/10.5114/wo.2015.46283
Kunc M, Gabrych A, Czapiewski P, Sworczak K. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn). 2015;19(1):6-16. doi: 10.5114/wo.2015.46283. Epub 2015 Mar 26. PMID: 26199564; PMCID: PMC4507891.
Copy Download .nbib Format: NLM
Williams-Beuren Syndrome: A Case Confirmed by Array-CGH Method.

Iranian journal of pediatrics

Jiang M, Liu L.
PMID: 26199689
Iran J Pediatr. 2015 Feb;25(1):e247. doi: 10.5812/ijp.247. Epub 2015 Feb 21.

No abstract available.

Cite
Jiang M, Liu L. Williams-Beuren Syndrome: A Case Confirmed by Array-CGH Method. Iran J Pediatr. 2015;25(1):e247doi: 10.5812/ijp.247.
Jiang, M., & Liu, L. (2015). Williams-Beuren Syndrome: A Case Confirmed by Array-CGH Method. Iranian journal of pediatrics, 25(1), e247. https://doi.org/10.5812/ijp.247
Jiang, MinYan, and Liu, Li. "Williams-Beuren Syndrome: A Case Confirmed by Array-CGH Method." Iranian journal of pediatrics vol. 25,1 (2015): e247. doi: https://doi.org/10.5812/ijp.247
Jiang M, Liu L. Williams-Beuren Syndrome: A Case Confirmed by Array-CGH Method. Iran J Pediatr. 2015 Feb;25(1):e247. doi: 10.5812/ijp.247. Epub 2015 Feb 21. PMID: 26199689; PMCID: PMC4505971.
Copy Download .nbib Format: NLM
Prevalence of General and Abdominal Obesity in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study.

Iranian journal of pediatrics

Esmaili H, Bahreynian M, Qorbani M, Motlagh ME, Ardalan G, Heshmat R, Kelishadi R.
PMID: 26199707
Iran J Pediatr. 2015 Jun;25(3):e401. doi: 10.5812/ijp.25(3)2015.401. Epub 2015 Jun 27.

BACKGROUND: Pediatric obesity is one of the predisposing risk factors for many non-communicable diseases.OBJECTIVES: The purpose of this study was to estimate the national prevalence of general and abdominal obesity among Iranian children and adolescents.PATIENTS AND METHODS: This cross-sectional...

Cite
Esmaili H, Bahreynian M, Qorbani M, et al. Prevalence of General and Abdominal Obesity in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study. Iran J Pediatr. 2015;25(3):e401doi: 10.5812/ijp.25(3)2015.401.
Esmaili, H., Bahreynian, M., Qorbani, M., Motlagh, M. E., Ardalan, G., Heshmat, R., & Kelishadi, R. (2015). Prevalence of General and Abdominal Obesity in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study. Iranian journal of pediatrics, 25(3), e401. https://doi.org/10.5812/ijp.25(3)2015.401
Esmaili, Haleh, et al. "Prevalence of General and Abdominal Obesity in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study." Iranian journal of pediatrics vol. 25,3 (2015): e401. doi: https://doi.org/10.5812/ijp.25(3)2015.401
Esmaili H, Bahreynian M, Qorbani M, Motlagh ME, Ardalan G, Heshmat R, Kelishadi R. Prevalence of General and Abdominal Obesity in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study. Iran J Pediatr. 2015 Jun;25(3):e401. doi: 10.5812/ijp.25(3)2015.401. Epub 2015 Jun 27. PMID: 26199707; PMCID: PMC4505989.
Copy Download .nbib Format: NLM
Erratum to: Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis.

Trials

Arch BN, Blair J, McKay A, Gregory JW, Newland P, Gamble C.
PMID: 28381235
Trials. 2017 Apr 05;18(1):164. doi: 10.1186/s13063-017-1914-7.

No abstract available.

Cite
Arch BN, Blair J, McKay A, et al. Erratum to: Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis. Trials. 2017;18(1):164doi: 10.1186/s13063-017-1914-7.
Arch, B. N., Blair, J., McKay, A., Gregory, J. W., Newland, P., & Gamble, C. (2017). Erratum to: Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis. Trials, 18(1), 164. https://doi.org/10.1186/s13063-017-1914-7
Arch, Barbara N, et al. "Erratum to: Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis." Trials vol. 18,1 (2017): 164. doi: https://doi.org/10.1186/s13063-017-1914-7
Arch BN, Blair J, McKay A, Gregory JW, Newland P, Gamble C. Erratum to: Measurement of HbA1c in multicentre diabetes trials - should blood samples be tested locally or sent to a central laboratory: an agreement analysis. Trials. 2017 Apr 05;18(1):164. doi: 10.1186/s13063-017-1914-7. PMID: 28381235; PMCID: PMC5382412.
Copy Download .nbib Format: NLM
Growth factor choice is critical for successful functionalization of nanoparticles.

Frontiers in neuroscience

Pinkernelle J, Raffa V, Calatayud MP, Goya GF, Riggio C, Keilhoff G.
PMID: 26388717
Front Neurosci. 2015 Sep 02;9:305. doi: 10.3389/fnins.2015.00305. eCollection 2015.

Nanoparticles (NPs) show new characteristics compared to the corresponding bulk material. These nanoscale properties make them interesting for various applications in biomedicine and life sciences. One field of application is the use of magnetic NPs to support regeneration in...

Cite
Pinkernelle J, Raffa V, Calatayud MP, et al. Growth factor choice is critical for successful functionalization of nanoparticles. Front Neurosci. 2015;9:305doi: 10.3389/fnins.2015.00305.
Pinkernelle, J., Raffa, V., Calatayud, M. P., Goya, G. F., Riggio, C., & Keilhoff, G. (2015). Growth factor choice is critical for successful functionalization of nanoparticles. Frontiers in neuroscience, 9305. https://doi.org/10.3389/fnins.2015.00305
Pinkernelle, Josephine, et al. "Growth factor choice is critical for successful functionalization of nanoparticles." Frontiers in neuroscience vol. 9 (2015): 305. doi: https://doi.org/10.3389/fnins.2015.00305
Pinkernelle J, Raffa V, Calatayud MP, Goya GF, Riggio C, Keilhoff G. Growth factor choice is critical for successful functionalization of nanoparticles. Front Neurosci. 2015 Sep 02;9:305. doi: 10.3389/fnins.2015.00305. eCollection 2015. PMID: 26388717; PMCID: PMC4557102.
Copy Download .nbib Format: NLM
Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents.

Frontiers in neuroanatomy

Kalló I, Molnár CS, Szöke S, Fekete C, Hrabovszky E, Liposits Z.
PMID: 26388742
Front Neuroanat. 2015 Sep 04;9:112. doi: 10.3389/fnana.2015.00112. eCollection 2015.

The ventral tegmental area (VTA) is a main regulator of reward and integrates a wide scale of hormonal and neuronal information. Feeding-, energy expenditure-, stress, adaptation- and reproduction-related hypothalamic signals are processed in the VTA and influence the reward...

Cite
Kalló I, Molnár CS, Szöke S, et al. Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents. Front Neuroanat. 2015;9:112doi: 10.3389/fnana.2015.00112.
Kalló, I., Molnár, C. S., Szöke, S., Fekete, C., Hrabovszky, E., & Liposits, Z. (2015). Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents. Frontiers in neuroanatomy, 9112. https://doi.org/10.3389/fnana.2015.00112
Kalló, Imre, et al. "Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents." Frontiers in neuroanatomy vol. 9 (2015): 112. doi: https://doi.org/10.3389/fnana.2015.00112
Kalló I, Molnár CS, Szöke S, Fekete C, Hrabovszky E, Liposits Z. Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents. Front Neuroanat. 2015 Sep 04;9:112. doi: 10.3389/fnana.2015.00112. eCollection 2015. PMID: 26388742; PMCID: PMC4559648.
Copy Download .nbib Format: NLM
Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.

Journal of bone metabolism

Kim CW, Hong S, Oh SH, Lee JJ, Han JY, Hong S, Kim SH, Nam M, Kim YS.
PMID: 26389089
J Bone Metab. 2015 Aug;22(3):135-41. doi: 10.11005/jbm.2015.22.3.135. Epub 2015 Aug 31.

Untreated hyperthyroidism and high-dose thyroid hormone are associated with osteoporosis, and increased bone mineral density (BMD) has been demonstrated in postmenopausal females with hypoparathyroidism. Studies on the effect of suppressive levothyroxine (LT4) therapy on BMD and bone metabolism after...

Cite
Kim CW, Hong S, Oh SH, et al. Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma. J Bone Metab. 2015;22(3):135-41doi: 10.11005/jbm.2015.22.3.135.
Kim, C. W., Hong, S., Oh, S. H., Lee, J. J., Han, J. Y., Hong, S., Kim, S. H., Nam, M., & Kim, Y. S. (2015). Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma. Journal of bone metabolism, 22(3), 135-41. https://doi.org/10.11005/jbm.2015.22.3.135
Kim, Chei Won, et al. "Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma." Journal of bone metabolism vol. 22,3 (2015): 135-41. doi: https://doi.org/10.11005/jbm.2015.22.3.135
Kim CW, Hong S, Oh SH, Lee JJ, Han JY, Hong S, Kim SH, Nam M, Kim YS. Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma. J Bone Metab. 2015 Aug;22(3):135-41. doi: 10.11005/jbm.2015.22.3.135. Epub 2015 Aug 31. PMID: 26389089; PMCID: PMC4572035.
Copy Download .nbib Format: NLM
CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Lajara R, Davidson JA, Nikkel CC, Morris TL.
PMID: 26866702
Endocr Pract. 2016 Jun;22(6):726-35. doi: 10.4158/EP151182.OR. Epub 2016 Feb 01.

OBJECTIVE: To compare two methods of delivering intensified insulin therapy (IIT) in patients with type 2 diabetes inadequately controlled on basal insulin ± concomitant antihyperglycemic agents in a real-world clinical setting.METHODS: Data for this retrospective study were obtained using...

Cite
Lajara R, Davidson JA, Nikkel CC, et al. CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN. Endocr Pract. 2016;22(6):726-35doi: 10.4158/EP151182.OR.
Lajara, R., Davidson, J. A., Nikkel, C. C., & Morris, T. L. (2016). CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 22(6), 726-35. https://doi.org/10.4158/EP151182.OR
Lajara, Rosemarie, et al. "CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 22,6 (2016): 726-35. doi: https://doi.org/10.4158/EP151182.OR
Lajara R, Davidson JA, Nikkel CC, Morris TL. CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN. Endocr Pract. 2016 Jun;22(6):726-35. doi: 10.4158/EP151182.OR. Epub 2016 Feb 01. PMID: 26866702.
Copy Download .nbib Format: NLM
The brain, obesity and addiction: an EEG neuroimaging study.

Scientific reports

De Ridder D, Manning P, Leong SL, Ross S, Sutherland W, Horwath C, Vanneste S.
PMID: 27658351
Sci Rep. 2016 Sep 23;6:34122. doi: 10.1038/srep34122.

Obesity is among the greatest challenges facing healthcare systems with 20% of the world's population afflicted. Great controversy exists whether obesity can be regarded as an addictive disorder or not. Recently the Yale Food Addiction Scale questionnaire has been...

Cite
De Ridder D, Manning P, Leong SL, et al. The brain, obesity and addiction: an EEG neuroimaging study. Sci Rep. 2016;6:34122doi: 10.1038/srep34122.
De Ridder, D., Manning, P., Leong, S. L., Ross, S., Sutherland, W., Horwath, C., & Vanneste, S. (2016). The brain, obesity and addiction: an EEG neuroimaging study. Scientific reports, 634122. https://doi.org/10.1038/srep34122
De Ridder, Dirk, et al. "The brain, obesity and addiction: an EEG neuroimaging study." Scientific reports vol. 6 (2016): 34122. doi: https://doi.org/10.1038/srep34122
De Ridder D, Manning P, Leong SL, Ross S, Sutherland W, Horwath C, Vanneste S. The brain, obesity and addiction: an EEG neuroimaging study. Sci Rep. 2016 Sep 23;6:34122. doi: 10.1038/srep34122. PMID: 27658351; PMCID: PMC5034231.
Copy Download .nbib Format: NLM
Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center.

BMJ open diabetes research & care

Ioja S, Chasens ER, Ng J, Strollo PJ, Korytkowski MT.
PMID: 28878943
BMJ Open Diabetes Res Care. 2017 Aug 09;5(1):e000433. doi: 10.1136/bmjdrc-2017-000433. eCollection 2017.

OBJECTIVE: Obstructive sleep apnea (OSA) and diabetes are frequent comorbid conditions. Screening for OSA in patients with diabetes is recommended but the frequency with which this is done in clinical practice is unknown. The objectives of this quality improvement...

Cite
Ioja S, Chasens ER, Ng J, et al. Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center. BMJ Open Diabetes Res Care. 2017;5(1):e000433doi: 10.1136/bmjdrc-2017-000433.
Ioja, S., Chasens, E. R., Ng, J., Strollo, P. J., & Korytkowski, M. T. (2017). Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center. BMJ open diabetes research & care, 5(1), e000433. https://doi.org/10.1136/bmjdrc-2017-000433
Ioja, Simona, et al. "Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center." BMJ open diabetes research & care vol. 5,1 (2017): e000433. doi: https://doi.org/10.1136/bmjdrc-2017-000433
Ioja S, Chasens ER, Ng J, Strollo PJ, Korytkowski MT. Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center. BMJ Open Diabetes Res Care. 2017 Aug 09;5(1):e000433. doi: 10.1136/bmjdrc-2017-000433. eCollection 2017. PMID: 28878943; PMCID: PMC5574455.
Copy Download .nbib Format: NLM
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

Oncotarget

Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M.
PMID: 28938636
Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.

Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal, proneural and neural, among which the mesenchymal and proneural subtypes have the shortest and longest survival,...

Cite
Guadagno E, Vitiello M, Francesca P, et al. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. Oncotarget. 2017;8(35):59282-59300doi: 10.18632/oncotarget.19546.
Guadagno, E., Vitiello, M., Francesca, P., Calì, G., Caponnetto, F., Cesselli, D., Camorani, S., Borrelli, G., Califano, M., Cappabianca, P., Arra, C., Crescenzi, E., Cerchia, L., De Caro, M. L. D. B., & Fedele, M. (2017). PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. Oncotarget, 8(35), 59282-59300. https://doi.org/10.18632/oncotarget.19546
Guadagno, Elia, et al. "PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype." Oncotarget vol. 8,35 (2017): 59282-59300. doi: https://doi.org/10.18632/oncotarget.19546
Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29. PMID: 28938636; PMCID: PMC5601732.
Copy Download .nbib Format: NLM
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Human reproduction (Oxford, England)

Tournaye H, Sukhikh GT, Kahler E, Griesinger G.
PMID: 28938733
Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266.

No abstract available.

Cite
Tournaye H, Sukhikh GT, Kahler E, et al. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017;32(10):2152doi: 10.1093/humrep/dex266.
Tournaye, H., Sukhikh, G. T., Kahler, E., & Griesinger, G. (2017). A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human reproduction (Oxford, England), 32(10), 2152. https://doi.org/10.1093/humrep/dex266
Tournaye, Herman, et al. "A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization." Human reproduction (Oxford, England) vol. 32,10 (2017): 2152. doi: https://doi.org/10.1093/humrep/dex266
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266. PMID: 28938733; PMCID: PMC6790500.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 63975 entries